StonvexLoading…
StonvexStonvexStonvexCore line items from LGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $1.04B | $2.55B | $1.81B | $505.95M |
Operating Income | $22.37M | $61.58M | $85.08M | $16.55M |
Net Income | $16.09M | $-59.78M | $-27.06M | $-21.21M |
EPS (Diluted) | $0.13 | $-0.57 | $-0.02 | Not available |
Total Assets | $3.48B | $2.68B | $2.60B | Not available |
Total Liabilities | $2.53B | $1.89B | $1.77B | Not available |
Cash & Equivalents | $244.62M | $230.17M | $176.03M | Not available |
Free Cash Flow OCF − CapEx | $102.29M | $218.93M | $137.39M | $24.10M |
Shares Outstanding | 108.43M | 59.38M | 58.51M | Not available |